Aptar CSP Technologies将在Vitafoods Europe上预览益生菌市场的两项新技术
公司还将介绍如何使用活性材料科学解决方案来优化益生菌配方以节省总体成本。 图 1：装有益生菌的 Avanti 瓶盖在活化时与水混合 亚拉巴马州奥本市，2023 年 5 [...]
U.S. FDA Approves Aptar’s Proprietary Activ-Film™ Technology for use with Rechargeable Implantable Neurostimulator
Sophisticated implantable medical device for urinary and bowel dysfunction leverages [...]
Aptar CSP Technologies’ Activ-Film™ Technology Protects New At-Home Prescription and OTC COVID-19 Tests
Auburn, AL, April 28, 2021 – Aptar CSP Technologies, a [...]
Aptar CSP Technologies Earns ISO Quality Certifications for Medical Device Production
Certification affirms the company’s quality management systems meets ISO requirements [...]
Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis
Crystal Lake, Illinois, February 15, 2021 - AptarGroup, Inc. (NYSE: [...]
Aptar CSP Technologies Increases Capacity for Active Packaging Solutions that Protect Diagnostic Test Kits
Patented 3-Phase Activ-Polymer™ platform technology protects electrochemical, lateral flow, and [...]
Probiotics Packaging Feature Article Published in Nutritional Outlook
Two of the most critical aspects of probiotics manufacturing and [...]
Aptar Submits Application for Emergency Use Authorization to the German Regulatory Agency BfArM for ActivShield™ FFP2 Decontamination System
Crystal Lake, Illinois, May 8, 2020 - AptarGroup, Inc. (NYSE: [...]
Aptar Requests U.S. FDA Emergency Use Authorization for ActivShield™ N95 Filtering Facepiece Respirator Decontamination System
Crystal Lake, Illinois, April 3, 2020 - AptarGroup, Inc. (NYSE: [...]
